Is Peptide Therapy Legal in Nevada?

Peptide legality is not one rule. It depends on which peptide, how you obtained it, and what you intend to do with it. The framework starts at the federal level with the FDA, which decides whether a peptide is an approved drug and whether a compounding pharmacy may lawfully prepare it. Nevada then layers its own pharmacy and medical-practice rules on top through state law and the Nevada State Board of Pharmacy.

The clearest legal path is the one real clinics use: a licensed provider evaluates you, writes a prescription for a specific medication, and a licensed U.S. pharmacy — either an FDA-approved manufacturer or a Section 503A/503B compounding pharmacy under federal compounding rules, dispenses it. That is legal in Nevada today. The gray-market path, ordering vials labeled “research use only” off the internet, is the one that creates legal and safety problems, and the FDA has publicly stated its concerns about unapproved peptide products marketed for human use.

This page is general legal and medical information for people researching peptide therapy in Las Vegas, Henderson, and across Nevada. It is not legal advice. For the answer that applies to you, bring your questions to an evaluation.

Yes. Peptide therapy is legal in Nevada when three conditions are met: a licensed physician or other authorized prescriber evaluates you in a real provider-patient relationship, a valid prescription is written for you as an individual patient, and the medication is dispensed by a licensed U.S. pharmacy. That is the entire legal basis for physician-led peptide therapy, and it is exactly how LiveNow Longevity operates.

Two bodies of law govern this. Federally, the FDA decides whether a peptide is an approved finished drug (semaglutide, tirzepatide), a substance a compounding pharmacy may lawfully prepare (under the Section 503A / 503B compounding framework), or neither. In Nevada, NRS Chapter 639 (Pharmacists and Pharmacy) and the Nevada State Board of Pharmacy govern who may prescribe, compound, and dispense within the state. As long as your care flows through those licensed channels, peptide therapy is legal.

What is not legal is the gray-market path: buying “research use only” vials online and injecting yourself, with no prescription, no evaluation, and no licensed pharmacy in the chain. That sits outside both the federal and the Nevada framework, regardless of how the seller labels the product.

Most physician-prescribed peptides — BPC-157, sermorelin, CJC-1295, ipamorelin, and others that are not FDA-approved finished drugs — are obtained through compounding pharmacies. Federal law recognizes two categories. A Section 503A pharmacy is a traditional pharmacy that compounds a medication for an identified individual patient against a specific prescription. A Section 503B facility is an outsourcing facility that operates under stricter federal standards and can produce larger batches.

Both are legal channels — but only for substances the FDA permits to be compounded. The FDA maintains lists of bulk drug substances that 503A and 503B facilities may use, and those lists determine which specific peptides are lawful to compound at any given time. When a peptide is removed from the list (as has happened with several substances through 2024–2026), it can no longer be lawfully compounded through that channel.

A note on the moving target

Federal rules on which specific peptides may be compounded have changed repeatedly through 2024–2026, and some compounds have moved on and off the permitted lists. Rather than quote a rule that may be out of date by the time you read it, we verify the current status of any peptide we consider for you at the time of your evaluation. If a compound cannot be sourced legally and safely, we will tell you — and we will not prescribe it. That is the only honest way to practice.

If you want peptide therapy the legal way — with a prescription, physician oversight, and a licensed U.S. pharmacy — the path is straightforward and starts the same whether you are in Las Vegas, Henderson, Summerlin, or rural Nevada.

• Start with an $88 medical evaluation with board-certified neurologist Dr. Charles Kamen, MD — history, goals, and (as indicated) baseline labs are reviewed before any peptide is considered.
• In-person at our southeast Las Vegas clinic at Eastern Avenue and the 215, serving Las Vegas, Henderson, Green Valley, and Summerlin.
• Telehealth for Nevada residents — the evaluation and follow-ups can be completed by secure video, with labs drawn at a location near you. Telemedicine prescribing is legal in Nevada when it is built on a real provider-patient relationship, not used to skip the evaluation.
• Medication dispensed by licensed U.S. pharmacies at pass-through cost with no markup — either FDA-approved product or a compounded preparation from a 503A/503B pharmacy, depending on what is clinically appropriate and lawfully available.

See our Las Vegas peptide clinic page for location and booking details, or learn whether you need a prescription for peptides.

• U.S. FDA — Human Drug Compounding (federal framework for Section 503A pharmacies and Section 503B outsourcing facilities).
• U.S. FDA — Bulk Drug Substances Used in Compounding (the lists that determine which peptides a 503A/503B pharmacy may lawfully compound).
• U.S. FDA — FDA’s Concerns About Unapproved GLP-1 Drugs Used for Weight Loss (the agency’s position on unapproved, non-FDA-approved peptide products marketed for human use).
• Nevada Revised Statutes, Chapter 639 — Pharmacists and Pharmacy (Nevada’s pharmacy practice and compounding statute).
• Nevada State Board of Pharmacy (licensing and consumer information for Nevada pharmacies and pharmacists).
• Müller TD, et al. Mol Metab. 2019;30:72-130. (Glucagon-like peptide 1 (GLP-1): physiology, satiety, and metabolism — background mechanism for GLP-1-pathway peptide drugs.)

Regulatory and legal background sources only — not a treatment claim. Federal compounding lists and enforcement positions change; the answer for your situation is the one a licensed physician gives you at your evaluation.